Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Suzanne L. Topalian | Researchclopedia

Back to researchers

Suzanne L. Topalian

Bloomberg (United States)ORCID

360

Works

96,654

Citations

101

h-index

212

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Affiliations

National Institutes of Health1987–2007

Bloomberg (United States)2016–2025

American Society of Clinical Oncology2006–2006

The University of Texas MD Anderson Cancer Center2010–2010

Howard Hughes Medical Institute2003–2003

Top Works

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian,F. Stephen Hodi,et al.

201212,535 citations

Immune Cell Function and Interaction

T-cell and B-cell Immunology

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer,Scott S. Tykodi,et al.

20127,944 citations

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian,Charles G. Drake,et al.

20154,170 citations

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer,Charles G. Drake,et al.

20102,913 citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Mark E. Dudley,John R. Wunderlich,et al.

20022,800 citations

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

James Chih‐Hsin Yang,Leah Haworth,et al.

20032,702 citations

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Suzanne L. Topalian,Janis M. Taube,et al.

20162,682 citations

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Richard A. Morgan,Mark E. Dudley,et al.

20062,561 citations

Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

Steven A. Rosenberg,Beverly S. Packard,et al.

19882,321 citations